Identifying New Therapeutic Targets via Modulation of Protein Corona Formation by Engineered Nanoparticles

From the “Silent Killer” to the “Whispering Disease”: Ovarian Cancer and the Uses of Metaphor

(2012) Patricia Jasen   MEDICAL HISTORY

The Evolution of the Protein Corona around Nanoparticles: A Test Study

(2011) Martin Lundqvist et al.   ACS Nano

Proteomic Characterization of Engineered Nanomaterial–Protein Interactions in Relation to Surface Reactivity

(2011) Jukka Sund et al.   ACS Nano

Sensitivity Improved Surface Plasmon Resonance Biosensor for Cancer Biomarker Detection Based on Plasmonic Enhancement

(2011) Wing-Cheung Law et al.   ACS Nano

Nanoparticle Size Is a Critical Physicochemical Determinant of the Human Blood Plasma Corona: A Comprehensive Quantitative Proteomic Analysis

(2011) Stefan Tenzer et al.   ACS Nano

Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems

(2011) Priya Prakash Karmali et al.   Expert Opinion on Drug Delivery

Physical−Chemical Aspects of Protein Corona: Relevance toin Vitroandin VivoBiological Impacts of Nanoparticles

(2011) Marco P. Monopoli et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge

(2011) Rochelle R. Arvizo et al.   Nanomedicine-Nanotechnology Biology and Medicine

A Facile Nanoparticle Immunoassay for Cancer Biomarker Discovery

(2011) Qun Huo et al.   JOURNAL OF NANOBIOTECHNOLOGY

Investigations on the Interactions between Plasma Proteins and Magnetic Iron Oxide Nanoparticles with Different Surface Modifications

(2010) Shujie Liu et al.   Journal of Physical Chemistry C

Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation

(2010) Zhou J. Deng et al.   Nature Nanotechnology

Strategies in the design of nanoparticles for therapeutic applications

(2010) Robby A. Petros et al.   NATURE REVIEWS DRUG DISCOVERY

Hepatoma-Derived Growth Factor Regulates the Bad-Mediated Apoptotic Pathway and Induction of Vascular Endothelial Growth Factor in Stomach Cancer Cells

(2010) Kyung Hee Lee et al.   ONCOLOGY RESEARCH

Cell biology through proteomics – ad astra per alia porci

(2010) John J.M. Bergeron et al.   TRENDS IN CELL BIOLOGY

Targeted Therapy in Ovarian Cancer

(2010) Lyndsay J. Willmott et al.   Journal of Oncology

Cellular Uptake of Densely Packed Polymer Coatings on Gold Nanoparticles

(2009) Mingtao Liang et al.   ACS Nano

Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy

(2009) Parag Aggarwal et al.   ADVANCED DRUG DELIVERY REVIEWS

Differential plasma protein binding to metal oxide nanoparticles

(2009) Zhou J Deng et al.   NANOTECHNOLOGY

Sensing of proteins in human serum using conjugates of nanoparticles and green fluorescent protein

(2009) Mrinmoy De et al.   Nature Chemistry

Evaluation of nanoparticle immunotoxicity

(2009) Marina A. Dobrovolskaia et al.   Nature Nanotechnology

Downregulation of hepatoma-derived growth factor activates the Bad-mediated apoptotic pathway in human cancer cells

(2008) Tsun Yee Tsang et al.   APOPTOSIS

The influence of protein adsorption on nanoparticle association with cultured endothelial cells

(2008) Morton S. Ehrenberg et al.   BIOMATERIALS

A One-Step Homogeneous Immunoassay for Cancer Biomarker Detection Using Gold Nanoparticle Probes Coupled with Dynamic Light Scattering

(2008) Xiong Liu et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY